News & Updates
Filter by Specialty:
Once-weekly semaglutide safe, effective in type 2 diabetes patients
Initiating a once-weekly treatment regimen of semaglutide helps control glycated haemoglobin (HbA1c) levels and body weight in patients with type 2 diabetes, without introducing new safety concerns, a Japan study has found.
Once-weekly semaglutide safe, effective in type 2 diabetes patients
13 Nov 2022Genetic, environmental factors drive metabolic disorder-related depression
The risk of depression is higher in individuals with endocrine-metabolic disorders, which can be explained by genetic and environmental influences, reveals a study.
Genetic, environmental factors drive metabolic disorder-related depression
12 Nov 2022Toe amputation effective in diabetics
Transmetatarsal amputation (TMA) appears to be an effective approach in diabetes management and can help avoid lower-extremity amputations (LEA), a recent study has found. However, patient-related factors such as insulin dependence and serum albumin affect the procedure’s efficacy.
Toe amputation effective in diabetics
12 Nov 2022Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
Patients with severe obesity and nonalcoholic fatty liver disease (NAFLD) appear to benefit from bariatric surgery, which significantly reduces the risk of cardiovascular disease (CVD), a study has found.
Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
09 Nov 2022High glycaemic burden associated with HCC development and fibrosis progression in patients with CHB + T2D
High glycaemic burden is associated with hepatocellular carcinoma (HCC) development and fibrosis progression in patients with chronic hepatitis B (CHB) and type 2 diabetes (T2D) (CHB + T2D), researchers from the University of Hong Kong (HKU) have reported.